These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20167141)

  • 1. Effect of therapeutic doses of mometasone furoate on cortisol levels in children with mild asthma.
    Skoner DP; Gentile DA; Angelini B
    Allergy Asthma Proc; 2010; 31(1):10-9. PubMed ID: 20167141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
    Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
    Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-daily evening dosing of mometasone furoate administered via a dry powder inhaler does not adversely affect the hypothalamic-pituitary-adrenal axis.
    Kosoglou T; Cutler DL; Staudinger H; Herron JM
    Chest; 2010 Jan; 137(1):115-21. PubMed ID: 19749003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of inhaled mometasone furoate on growth velocity and adrenal function: a placebo-controlled trial in children 4-9 years old with mild persistent asthma.
    Skoner DP; Meltzer EO; Milgrom H; Stryszak P; Teper A; Staudinger H
    J Asthma; 2011 Oct; 48(8):848-59. PubMed ID: 21854342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mometasone furoate has minimal effects on the hypothalamic-pituitary-adrenal axis when delivered at high doses.
    Affrime MB; Kosoglou T; Thonoor CM; Flannery BE; Herron JM
    Chest; 2000 Dec; 118(6):1538-46. PubMed ID: 11115437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic-pituitary-adrenal axis effects of mometasone furoate/formoterol fumarate vs fluticasone propionate/salmeterol administered through metered-dose inhaler.
    Kosoglou T; Hubbell J; Cutler DL; Johnson-Levonas AO; Xu D; Kantesaria BS; Kim K; Miller SD
    Chest; 2013 Dec; 144(6):1795-1802. PubMed ID: 24077095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma.
    Karpel JP; Nelson H
    Curr Med Res Opin; 2007 Nov; 23(11):2897-911. PubMed ID: 17922978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma.
    Berger WE; Milgrom H; Chervinsky P; Noonan M; Weinstein SF; Lutsky BN; Staudinger H
    Ann Allergy Asthma Immunol; 2006 Nov; 97(5):672-80. PubMed ID: 17165278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparable morning versus evening administration of once-daily mometasone furoate dry powder inhaler.
    Zetterström O; Dahl R; Lindqvist A; Olsson P
    Respir Med; 2008 Oct; 102(10):1406-11. PubMed ID: 18640826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
    Bernstein DI; Berkowitz RB; Chervinsky P; Dvorin DJ; Finn AF; Gross GN; Karetzky M; Kemp JP; Laforce C; Lumry W; Mendelson LM; Nelson H; Pearlman D; Rachelefsky G; Ratner P; Repsher L; Segal AT; Selner JC; Settipane GA; Wanderer A; Cuss FM; Nolop KB; Harrison JE
    Respir Med; 1999 Sep; 93(9):603-12. PubMed ID: 10542973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mometasone furoate dry-powder inhaler for the control of persistent asthma.
    D'Urzo A
    Expert Opin Pharmacother; 2007 Nov; 8(16):2871-84. PubMed ID: 17956206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma.
    Nayak AS; Banov C; Corren J; Feinstein BK; Floreani A; Friedman BF; Goldsobel A; Gottschlich GM; Hannaway PJ; Lampl KL; Lapidus RJ; Lawrence M; Lumry W; Munk Z; Pearlman D; Scardella AT; Schenkel EJ; Segal AT; Segall N; Silverman B; Shneyer L; Nolop KB; Harrison JE
    Ann Allergy Asthma Immunol; 2000 Apr; 84(4):417-24. PubMed ID: 10795650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety of mometasone furoate administered via a dry powder inhaler in children: Results of an open-label study comparing mometasone furoate with beclomethasone dipropionate in children with persistent asthma.
    Noonan M; Leflein J; Corren J; Staudinger H
    BMC Pediatr; 2009 Jul; 9():43. PubMed ID: 19594937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mometasone furoate administered via a dry powder inhaler once daily in the evening on nocturnal lung function and sleep parameters in patients with moderate persistent asthma: a randomized, double-blind, placebo-controlled pilot study.
    Krouse JH; Krouse HJ; Janisse JJ
    Clin Drug Investig; 2009; 29(1):51-8. PubMed ID: 19067474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of mometasone furoate administered once-daily in the evening in patients with persistent asthma dependent on inhaled corticosteroids.
    D'Urzo A; Karpel JP; Busse WW; Boulet LP; Monahan ME; Lutsky B; Staudinger H
    Curr Med Res Opin; 2005 Aug; 21(8):1281-9. PubMed ID: 16083538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily evening administration of mometasone furoate in asthma treatment initiation.
    Bensch GW; Prenner B; Berkowitz R; Galant S; Ramsdell J; Lutsky B
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):533-40. PubMed ID: 16680923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of mometasone furoate administered via a dry powder inhaler in the treatment of asthma.
    Zeidler M; Corren J; Tashkin DP
    Curr Med Res Opin; 2010 Jun; 26(6):1295-305. PubMed ID: 20370376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma.
    Corren J; Berkowitz R; Murray JJ; Prenner B
    Int J Clin Pract; 2003 Sep; 57(7):567-72. PubMed ID: 14529054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator.
    O'Connor B; Bonnaud G; Haahtela T; Luna JM; Querfurt H; Wegener T; Lutsky BN
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):397-404. PubMed ID: 11345282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoate.
    Daley-Yates PT; Deans A; Mehta R; Sousa AR
    Pulm Pharmacol Ther; 2022 Dec; 77():102171. PubMed ID: 36243386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.